All In Biotech

Free tool

FAERS Monitor: Lovenox

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022138 or its brand name (Lovenox, Enoxaparin Sodium). Reports on generic versions are filed under their own applications.

Reports

58,051

Serious

50,417

87% of reports

Hospitalization

31,135

Death reported

8,973

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use2,665
  • dyspnoea2,456
  • nausea2,434
  • diarrhoea2,330
  • anaemia2,259
  • thrombocytopenia2,131
  • pyrexia2,098
  • fatigue2,034
  • vomiting1,905
  • pulmonary embolism1,831
  • death1,772
  • pneumonia1,716
  • asthenia1,650
  • acute kidney injury1,621
  • fall1,573

Reports by year received

View as table
YearReports
20041,257
20051,329
20061,244
20071,240
20081,501
20091,763
20101,941
20112,327
20122,297
20131,935
20142,315
20152,754
20162,904
20172,745
20183,649
20193,436
20203,596
20213,368
20223,956
20233,666
20243,309
20253,268
20262,249

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,996,108 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
pulmonary embolismSignal1,8317.16.89,445
thrombocytopeniaSignal2,1317.06.710,842
anaemiaSignal2,2594.34.25,768
acute kidney injurySignal1,6213.93.73,433
pyrexiaSignal2,0982.22.11,393
pneumonia1,7161.91.8770
fall1,5731.71.6474
asthenia1,6501.61.5368
dyspnoea2,4561.61.5526
vomiting1,9051.51.4291
diarrhoea2,3301.31.3174
nausea2,4341.11.130
off label use2,6651.11.127
fatigue2,0340.90.96
death1,7720.70.7161

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.